How Long for Semaglutide to Get Out of Your System

Step 1 — the half-life explained: why five weeks, not one

Every medicine has a half-life: the time it takes for the concentration in your blood to fall by half. For semaglutide, that figure is approximately seven days. Because concentrations roughly halve each week, the maths works like this: after one week you have about 50% remaining; after two weeks, around 25%; after three, roughly 12%; after four, around 6%; after five, less than 4%. At that point, pharmacologists consider the drug effectively cleared from the system. So the honest answer to how long before semaglutide is out of your system is close to five full weeks from your last injection.

One misconception worth setting straight: many people assume the effects vanish the moment the drug does. In practice, changes in appetite and body weight can rebound well before five weeks are up, sometimes within ten to fourteen days of the last dose, because appetite hormones begin reasserting themselves before plasma concentrations reach zero. The pharmacological clearance timeline and the clinical effects timeline do not run together in perfect step.

Higher doses may take slightly longer to clear in absolute terms because the starting plasma concentration is greater, but the half-life itself does not change with dose. The NHS page on semaglutide notes that the drug binds strongly to albumin in the blood, which is part of what gives it its unusually long half-life compared with older GLP-1 medicines.

Step 2 — what you notice during those five weeks

The first thing most people report after stopping Wegovy is a gradual return of hunger, usually beginning within the first week or two. Because semaglutide slows gastric emptying and suppresses appetite signals, its absence allows those signals to recover relatively quickly. Nausea or digestive side effects, if still present near the time of stopping, will also resolve during this window, typically faster than the drug fully clears.

Weight tends to be stable for a short period after the final injection, then often begins to increase as appetite returns. Clinical trial data show that participants who stopped semaglutide after 68 weeks regained a significant proportion of their lost weight within a year. That is not a reason to avoid stopping when stopping is the right clinical decision; it is a reason to have a plan in place, ideally agreed with your prescriber before the last pen is used.

If you want to understand the opposite end of this timeline, how long semaglutide takes to reach steady state is a useful companion question, the drug takes a similar number of weeks to build up as it does to clear.

Step 3, situations where the clearance window is clinically important

There are three main scenarios where the five-week figure becomes practically significant.

Surgery. NHS England advises patients to inform their anaesthetist that they take a GLP-1 medicine before any surgical procedure. Slowed gastric emptying can affect the risk of aspiration under anaesthesia. Many surgical teams will ask you to stop Wegovy at least one or two weeks before an elective procedure; some request longer. Your prescriber and surgical team should agree the timing together.

Pregnancy and conception. The MHRA advises using effective contraception while taking semaglutide. For those planning a pregnancy, the medicine should be stopped and sufficient time allowed for clearance before conception. The five-week clearance estimate is the basis for standard wash-out guidance, though your prescriber will give you the specific advice relevant to your circumstances. The NHS England weight-management injections page outlines the contraception and conception advice in more detail.

Switching treatments. If you are moving from Wegovy to another medicine, your prescriber will factor the residual semaglutide in your system into the timing. Overlapping GLP-1 medicines is not appropriate, and the clearance window helps set the safe restart or switch date. If you are curious about how long Wegovy stays in your system, including what affects that timeline for different people, our dedicated page covers this in full detail. For context on what Wegovy costs and how the private prescription process works, the Wegovy pricing page covers the honest picture on private treatment in the UK.

Step 4, what this means for restarting or stopping permanently

Stopping Wegovy is a prescription decision, not a logistical one. If you are considering it, speak with your prescriber rather than simply not ordering your next pen. There are a few reasons for that. First, the dose titration history matters if you restart: starting again at the maintenance dose after a gap risks more pronounced side effects. Second, your prescriber may want to plan lifestyle and dietary support to reduce the risk of weight regain during the clearance and post-clearance period. Third, if the reason for stopping is a side effect, there may be an alternative approach worth discussing before discontinuing entirely.

For those on the Wegovy injection wondering about the broader treatment landscape, the Wegovy overview page sets out what the medicine is licensed for, how the titration schedule works, and who it is suitable for clinically. And if you are at an earlier stage and still exploring whether treatment is right for you, the six-week results page gives a realistic picture of the early weeks on treatment, which provides useful context for understanding what you'd be pausing.

Semaglutide (Wegovy) is a prescription-only medicine; a GPhC-registered prescriber determines suitability, the appropriate dose, and the plan around stopping or restarting. Self-managing those decisions without clinical input carries real risk.